Matches in SemOpenAlex for { <https://semopenalex.org/work/W2415577467> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2415577467 endingPage "82" @default.
- W2415577467 startingPage "1474" @default.
- W2415577467 abstract "As a result of intensive recent research, the molecular mechanisms governing the human fibrinolytic system could be elucidated. Clinical trials using streptokinase and urokinase demonstrated that therapeutic thrombolysis is a valuable regimen in the treatment of patients with thromboembolic diseases. After unsuccessful attempts to increase the clot specificity of these agents, efforts were increased towards developing fibrin-specific substances with high thrombolytic potency and negligible effects on systemic hemostasis. Tissue-type plasminogen activator manufactured by recombinant DNA technology (rt-PA) is currently the most comprehensively investigated fibrin-specific thrombolytic agent with the most clearly understood mechanism of action in vivo. Pro-urokinase has also become available through biotechnology. A large number of clinical trials studying thrombolytic therapy of myocardial infarction have proved that intravenous rt-PA posesses superior efficacy compared to conventional fibrinolytic agents. Comparatively few clinical studies have been performed using pro-urokinase. At therapeutic doses, the fibrin specificities of these agents differ. So far it has not been possible to correlate the incidence of bleeding complications during fibrinolytic therapy with alterations in hemostasis parameters. For routine laboratory monitoring of thrombolysis the determination of fibrinogen and thrombin clotting time can be recommended. New developments with potential for yielding the next generation of thrombolytic agents are mutants and chimeras of t-PA and pro-urokinase, and conjugates of these substances with fibrin specific antibodies." @default.
- W2415577467 created "2016-06-24" @default.
- W2415577467 creator A5013913272 @default.
- W2415577467 creator A5088797832 @default.
- W2415577467 date "1989-11-01" @default.
- W2415577467 modified "2023-09-23" @default.
- W2415577467 title "Current developments in thrombolytic therapy using novel plasminogen activators." @default.
- W2415577467 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2695093" @default.
- W2415577467 hasPublicationYear "1989" @default.
- W2415577467 type Work @default.
- W2415577467 sameAs 2415577467 @default.
- W2415577467 citedByCount "1" @default.
- W2415577467 crossrefType "journal-article" @default.
- W2415577467 hasAuthorship W2415577467A5013913272 @default.
- W2415577467 hasAuthorship W2415577467A5088797832 @default.
- W2415577467 hasConcept C126322002 @default.
- W2415577467 hasConcept C181199279 @default.
- W2415577467 hasConcept C185592680 @default.
- W2415577467 hasConcept C203014093 @default.
- W2415577467 hasConcept C2776336681 @default.
- W2415577467 hasConcept C2776572282 @default.
- W2415577467 hasConcept C2776825266 @default.
- W2415577467 hasConcept C2776892390 @default.
- W2415577467 hasConcept C2777377995 @default.
- W2415577467 hasConcept C2778589496 @default.
- W2415577467 hasConcept C2779036427 @default.
- W2415577467 hasConcept C2779581417 @default.
- W2415577467 hasConcept C2779679481 @default.
- W2415577467 hasConcept C2781071845 @default.
- W2415577467 hasConcept C2909817843 @default.
- W2415577467 hasConcept C500558357 @default.
- W2415577467 hasConcept C54173615 @default.
- W2415577467 hasConcept C55493867 @default.
- W2415577467 hasConcept C71924100 @default.
- W2415577467 hasConcept C98274493 @default.
- W2415577467 hasConceptScore W2415577467C126322002 @default.
- W2415577467 hasConceptScore W2415577467C181199279 @default.
- W2415577467 hasConceptScore W2415577467C185592680 @default.
- W2415577467 hasConceptScore W2415577467C203014093 @default.
- W2415577467 hasConceptScore W2415577467C2776336681 @default.
- W2415577467 hasConceptScore W2415577467C2776572282 @default.
- W2415577467 hasConceptScore W2415577467C2776825266 @default.
- W2415577467 hasConceptScore W2415577467C2776892390 @default.
- W2415577467 hasConceptScore W2415577467C2777377995 @default.
- W2415577467 hasConceptScore W2415577467C2778589496 @default.
- W2415577467 hasConceptScore W2415577467C2779036427 @default.
- W2415577467 hasConceptScore W2415577467C2779581417 @default.
- W2415577467 hasConceptScore W2415577467C2779679481 @default.
- W2415577467 hasConceptScore W2415577467C2781071845 @default.
- W2415577467 hasConceptScore W2415577467C2909817843 @default.
- W2415577467 hasConceptScore W2415577467C500558357 @default.
- W2415577467 hasConceptScore W2415577467C54173615 @default.
- W2415577467 hasConceptScore W2415577467C55493867 @default.
- W2415577467 hasConceptScore W2415577467C71924100 @default.
- W2415577467 hasConceptScore W2415577467C98274493 @default.
- W2415577467 hasIssue "11" @default.
- W2415577467 hasLocation W24155774671 @default.
- W2415577467 hasOpenAccess W2415577467 @default.
- W2415577467 hasPrimaryLocation W24155774671 @default.
- W2415577467 hasRelatedWork W1983062545 @default.
- W2415577467 hasRelatedWork W2059988535 @default.
- W2415577467 hasRelatedWork W2071904621 @default.
- W2415577467 hasRelatedWork W2076806700 @default.
- W2415577467 hasRelatedWork W2399692975 @default.
- W2415577467 hasRelatedWork W2413149650 @default.
- W2415577467 hasRelatedWork W2415577467 @default.
- W2415577467 hasRelatedWork W2418627920 @default.
- W2415577467 hasRelatedWork W356210919 @default.
- W2415577467 hasRelatedWork W93220163 @default.
- W2415577467 hasVolume "39" @default.
- W2415577467 isParatext "false" @default.
- W2415577467 isRetracted "false" @default.
- W2415577467 magId "2415577467" @default.
- W2415577467 workType "article" @default.